Tanusree Sen, PhD, joined the University of Pittsburgh Department of Neurological Surgery in March of 2017 as a research assistant professor.
As part of her PhD training, she developed expertise in the area of oxidative stress-mediated cellular dysfunctions and brain aging. After her graduation from the University of Calcutta in 2007, she joined the research group of David Sidransky, MD, at Johns Hopkins University’s Division of Head and Neck Cancer. In Dr. Sidransky lab, Dr. Sen worked on multiple projects unraveling the molecular pathways and mechanism involving different cancers including cigarette smoking-induced bladder cancer. Her work studied the mechanism involved p53 isoform, p63 for cell death and chemoresistance. She discovered novel mechanisms which were shown to play a key role in cell death associated with several different cancers. In a separate project of age-related macular degeneration, she discovered the key role of lens structural protein CRYBA1 in anoikis and autophagy process in mouse retinal astrocytes and retinal pigmented epithelial cells.
In 2012, Dr. Sen joined Augusta University as a postdoctoral fellow and extended her expertise of cellular-molecular biology in the field of immunology, autoimmunity and traumatic brain injury and discovered molecular mechanism regulating neuronal death and memory function after traumatic brain injury.
In 2015, Dr. Sen started working as a research assistant professor at the University of Georgia and worked on the mechanism of diet-induced vagal nerve injury specifically in the context of the gut-microbiota-inflammation-brain axis. At this time, she discovered how different diet might contribute to gut microbial dysbiosis, inflammation and subsequently damage to the vagal nerve. Dr. Sen has published 37 papers in refereed journals with total citations have exceeded 2500.
Specialized Areas of Interest
Professional Organization Membership
Education & Training
- BSc, Chemistry, Calcutta University, India 1998
- MSc, Biochemistry, Calcutta University, India, 2000
- PhD, Brain Aging, University of Calcutta, 2006
- Fellow, Head and Neck Cancer, Johns Hopkins, 2010
- Fellow, Cancer Immunology and Neuroscience, Augusta University, 2014
Honors & Awards
- Best Oral Presentation Award, International Symposium on Free Radical Research, India, 2006
- Finalist, Young Scientist Award Lecture, Society for Free Radical Research, India, 2006
Sen T, Gupta R, Kaiser H, Sen N. Activation of PERK Elicits Memory Impairment through Inactivation of CREB and Downregulation of PSD95 After Traumatic Brain Injury. J Neurosci 37(24):5900-5911, 2017.
Vaughn AC, Cooper EM, DiLorenzo PM, O'Loughlin LJ, Konkel ME, Peters JH, Hajnal A, Sen T, Lee SH, de La Serre CB, Czaja K. Energy-dense diet triggers changes in gut microbiota, reorganization of gut‑brain vagal communication and increases body fat accumulation. Acta Neurobiol Exp (Wars) 77(1):18-30, 2017.
Sen T, Cawthon CR, Ihde BT, Hajnal A, DiLorenzo PM, de La Serre CB, Czaja K. Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity. Physiol Behav 173:305-317, 2017.
Sen T, Sen, N. Isoflurane-induced inactivation of CREB through histone deacetylase 4 is responsible for cognitive impairment in developing brain. Neurobiol Dis 96:12-21, 2016
Sen T, Sen N. Treatment with an activator of hypoxia-inducible factor 1, DMOG provides neuroprotection after traumatic brain injury. Neuropharmacology 107:79-88, 2016.
Mir S, Sen T, Sen N. Cytokine-induced GAPDH sulfhydration effects PSD95 degradation and memory. Mol Cell 56:786, 2014.
Sen T, Sen N, Noordhuis MG, Ravi R. Wu TC, Ha PK, Sidransky D, Hoque MO. OGDHL is a modifier of AKT-dependent signaling and NF-kB function. PLoS One 7(11):e48770, 2012.
Sen N, Paul BD, Gadalla MM, Mustafa AK, Sen T, Kim S, Snyder SH. Hydrogen sulfide-linked sulfhydration of NF-kB mediates its anti-apoptotic actions. Mol Cell 45(1),13-24, 2012
Sen T. Sen N, Huang Y, Sinha D, Ratovitski E, Sidransky D. Tumor protein p63/nuclear factor kappa-B axis in regulation of cell death. J Biol Chem 286(50): 43204-13, 2011.
Sen T, Sen N, Brait M, Begum S, Chatterjee A, Hoque M, Ratovitski E, Sidransky D. ΔNp63alpha confers tumor cell resistance to cisplatin treatment through the transcriptional regulation of AKT. Cancer Res 71(3):1167-76, 2011.
Sen T, Chang X, Sidransky D, Chatterjee A. Regulation of ΔNp63α by NF-κΒ. Cell Cycle 9(24):4841-7, 2010.
Huang Y, Sen T, Nagpal J, Upadhyay S, Trink B, Ratovitski E, Sidransky D. Equal contributory first author. ATM kinase is a master switch for the ΔNp63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage. Cell Cycle 7(18), 2846-55, 2008.
A complete list of Dr. Sen's publications can be reviewed through the National Library of Medicine's publication database.
Dr. Sen is currently working on the function of transcription factor p63 in TBI pathology. Preliminary data indicate that a transcription factor p63, which is a family member of the tumor suppressor p53, contributes to the pathological outcomes of TBI in several layers. In addition, Dr. Sen is in the process of understanding the cellular and molecular mechanism of how p63 regulates the oxidative/ER stress, alteration in mitochondrial structure and function and cognitive impairment.
Dr. Sen has also been working to understand whether and how the immune cells from the periphery contributes to brain immunological response following TBI. In general, the peripheral immune cells cannot enter into the brain because they cannot pass through the blood-brain barrier. However, in TBI patients, the existence of peripheral immune cells have been identified, but their role in the pathogenicity has not been studied well. The major objective of this project is to understand how these cells enter into the brain and whether they function independently or in association with the residential immune cells in the brain following TBI. Dr. Sen would like to combine her experience of studying oncogenic transcription factors and function of immunological cells with the expertise of studying several aspects of TBI-pathology to accomplish the goals and objectives of current projects.